← Back to Search

Living ACTS Education for Kidney Transplant Candidates

N/A

Waitlist Available

Led By Rachel Patzer, PhD, MPH, FAST

Research Sponsored by Emory University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 12 months

Awards & highlights

Study Summary

This trial is studying how well a systems-level intervention (T-REX) and a culturally-sensitive individual-level educational intervention (web-based Living ACTS: About Choices in Transplantation and Sharing) work in increasing living donor kidney transplantation (LDKT) in African American patients with end stage renal disease (ESRD).

Who is the study for?

This trial is for English-speaking African American or Black patients, aged 18 to 65 with a BMI under 35, who have end-stage renal disease and are being evaluated for kidney transplantation at one of the four study sites within the study period.Check my eligibility

What is being tested?

The trial is testing whether a web-based educational tool called Living ACTS and standard transplant education can increase living donor inquiries among friends/family. It aims to reduce racial disparities in access to living donor kidney transplants.See study design

What are the potential side effects?

Since this trial involves educational interventions rather than medical treatments, there are no direct physical side effects expected from participating in this study.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in percent of patients with at least one inquiry from a potential living donor

Secondary outcome measures

Change in confidence in initiating a conversation about LDKT

Change in knowledge and understanding of donation/transplantation assessment score

Change in motivation scale score to ask a family member to be a living donor

Other outcome measures

Change in intention to discuss LDKT with family members

Comprehensive and final list of website modifications.

Trial Design

2Treatment groups

Experimental Treatment

Group I: Standard transplant education proceduresExperimental Treatment1 Intervention

Usual Care, which involves the provision of standard transplant education procedures at each transplant center, which entail reviewing a packet of information with the pre-transplant coordinator. The packet serves to inform transplant candidates and their families about the option living donor kidney transplantation (LDKT). In addition, participants will be provided an iPad/tablet to watch two 10-minute National Kidney Foundation videos about kidney disease and transplantation in their private room during their regularly scheduled KT evaluation. This video discusses information about transplant, but does not specifically address LDKT and is not culturally-sensitive to African American population.

Group II: Living ACTS websiteExperimental Treatment2 Interventions

In addition to the provision of standard transplant education procedures, a patient will watch the Living ACTS video (embedded in the Living ACTS website) along with any family members or friends who are accompanying a patient. Plus minimum of 5 minutes navigating the website (aside from watching the 20-minute video).

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Emory UniversityLead Sponsor

1,636 Previous Clinical Trials

2,560,157 Total Patients Enrolled

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH

2,357 Previous Clinical Trials

4,314,770 Total Patients Enrolled

Rachel Patzer, PhD, MPH, FASTPrincipal Investigator - Emory University

Emory University

Media Library

Standard transplant education procedures Clinical Trial Eligibility Overview. Trial Name: NCT03819686 — N/A

Kidney Transplant Research Study Groups: Living ACTS website, Standard transplant education procedures

Kidney Transplant Clinical Trial 2023: Standard transplant education procedures Highlights & Side Effects. Trial Name: NCT03819686 — N/A

Standard transplant education procedures 2023 Treatment Timeline for Medical Study. Trial Name: NCT03819686 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current sample size of this research study?

"Accurately, clinicaltrials.gov shows that this experiment is presently recruiting participants. This trial was initially posted on February 4th 2019 and edited as recently as April 19th 2022. The investigation requires 850 patients to be recruited from just one medical centre."

Answered by AI

Are there still open opportunities to join this experimental endeavor?

"Affirmative. According to information hosted on clinicaltrials.gov, recruitment for this medical endeavour is still ongoing; it was first posted in February 2019 and last revised in April 2022. The study requires 850 participants from a single site."

Answered by AI

Does the trial allow for participants aged 35 and older?

"This medical trial has an age requirement, requiring that potential participants must be at least 18 years of age and not older than 65."

Answered by AI

Under what conditions can individuals take part in this research?

"To be accepted into this clinical trial, individuals must possess functional kidneys and meet the age criteria of 18 to 65 years old. In total, 850 patients are needed for enrollment."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Reducing Disparities in Living Donor Transplant Among African Americans

Rachel Patzer 2019. "Reducing Disparities in Living Donor Transplant Among African Americans". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03819686.